Exploring the role of EpCAM in early-stage hepatocellular carcinoma progression

Announcing a new publication for Acta Materia Medica journal. Epithelial cell adhesion molecule (EpCAM) is a biomarker for epithelial cell-derived tumors.

Faron Pharma secures UK innovation passport for blood cancer immunotherapy – Pharmaceutical Technology

The MHRA has given the green light to Faron to conduct the BEXMAB clinical trial in the UK. Credit: Andreas_Bergerstedt via Shutterstock. Faron Pharmaceuticals is

December 4, 2024

Rise in weight-management glucose-lowering drug prescriptions in type 1 diabetes patients

From 2010 to 2023, GLP-1RAs and SGLT2 inhibitors saw rising prescriptions in type 1 diabetes, particularly for patients with obesity and cardiorenal risks.

October 23, 2024

UK-based Verdiva launches with $410m and an oral GLP-1RA candidate – Pharmaceutical Technology

Verdiva aims to advance a portfolio of next-generation oral and injectable treatments with first-in-class or best-in-class potential. Credit: Nuthawut Somsuk via Getty Images. As the

January 9, 2025

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.